GLG News by Acular/Acular LS (Ketorolac Tromethamine) Prescribers: Ophthalmologists (US)
Request a free trial
April 16, 2007
Now Hold On!
Analysis of: LASEK effectively treated post-LASIK myopic regression in study | www.osnsupersite.com
Author: GLG Expert Contributor
Analysis of: LASEK effectively treated post-LASIK myopic regression in study | www.osnsupersite.com
Author: GLG Expert Contributor
An argument can be made for LASEK over LASIK for the initial laser treatment in some patients, but the re-lifting of the lasik flap and performing a laser re treatment is the management of choice in almost all cases of post lasik myopic regression. An exception would be if the cornea is too thin or...
April 16, 2007Newly identified risks for refractive surgery
Analysis of: Researchers report 13 cases of MRSA keratitis after laser refractive surgery | www.osnsupersite.com
Author: Barry Schechter, Director of Corneal and External Diseases, Florida Eye Microsurgical Institute, Inc.
Refractive surgery is taken for granted by patients to "get rid of their glasses and contact lenses". They rarely consider the possibility of loss of vision.
April 9, 2007
VEGF Trap offers New Approach to fight ocular angiogenesis.
Analysis of: Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration | www.pipelinereview.com
Author: GLG Expert Contributor
Analysis of: Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration | www.pipelinereview.com
Author: GLG Expert Contributor
The VEGF Trap from Regeneron is a protein made up off human VEGF receptors fused to human immunoglobulin. This compound binds VEGF, preventing VEGF from binding to its natural receptors, interrupting the angiogenic cascade. The phase II study showed promising...
March 28, 2007Impact of the Avastin/Lucentis controversy on the rest of ophthalmology
Analysis of: Retinal specialist on the Avastin/Lucentis Controversy | patentdocs.typepad.com
Author: Sanjay Rao, Medical Director, Lakeside Eye Clinic
This article describes the perspective of a retinal specialist on the Avastin/Lucentis controversy. In mid-February the National Institutes of Health announced that it would conduct a head to head trial comparing the effectiveness of Lucentis and Avastin for the treatment of wet age...
March 21, 2007Multifocal contact lenses unlikely to impact market for surgical correction
Analysis of: Better Vision Without Looking Your Age | www.nytimes.com
Author: Sanjay Rao, Medical Director, Lakeside Eye Clinic
This New York Times article describes many of the vision correction options available to individuals with presbyopia. Because of the growing population of baby boomers, there is significant public interest in options that allow individuals freedom from reading glasses. Multifocal contact...
March 21, 2007Alcon's Aqualase System: A safer approach to cataract surgery?
Analysis of: AquaLase shows trend toward less foveal thickening in diabetic patients | www.osnsupersite.com
Author: Sanjay Rao, Medical Director, Lakeside Eye Clinic
This article presents the results of a study comparing standard phacoemulsification to Aqualase. Complication rates were similar between the two procedures. The 63 patient study looked in particular at foveal thickening after surgery. While no statistical significance was demonstrated,...
March 9, 2007Corneal inlays: Another entrant into the presbyopia treatment wars
Analysis of: Corneal inlay is versatile approach for presbyopia | www.ophthalmologytimes.com
Author: Sanjay Rao, Medical Director, Lakeside Eye Clinic
The early results of a new corneal inlay (PresbyLens, ReVision Optics) are presented. A corneal inlay is placed underneath a LASIK corneal flap in the non-dominant eye to correct presbyopia. This version of a corneal inlay is 1.5mm in diameter. The outcomes of 15 patients showed good...
March 7, 2007Approval of Aspheric Restor lens: Another winner for Alcon?
Analysis of: Alcon's AcrySof(R) ReSTOR(R) Apodized Diffractive Aspheric Intraocular Lens Approved by FDA | biz.yahoo.com
Author: Sanjay Rao, Medical Director, Lakeside Eye Clinic
The recent approval of the aspheric version of the Restor multifocal intraocular lens is positive as most surgeons already understand the value of aspheric optics. As shown with monofocal aspheric lenses, such as the Alcon IQ, Advanced Medical Optics' Tecnis, and Bausch and Lomb's Sofport, aspheric...
March 7, 2007Concerns about billing for multifocal IOLs may limit growth
Analysis of: Presbyopia-correcting IOLs present opportunity, but legal caution needed | www.osnsupersite.com
Author: Sanjay Rao, Medical Director, Lakeside Eye Clinic
The article describes some of the legal concerns in billing for presbyopia-correcting IOLs. The ruling by the CMS (Centers for Medicaid and Medicare Services) in 2005 that essentially allowed surgeons to charge patients an additional out-of-pocket cost related to the implantation of these lenses...
March 7, 2007Xibrom: A potential blockbuster for post-operative eye pain?
Analysis of: ISTA Pharmaceuticals Announces Positive Preliminary Xibrom Once-daily Formulation Clinical Results From U.S. Phase III Trials | pharmalive.com
Author: Sanjay Rao, Medical Director, Lakeside Eye Clinic
The Phase III Trials of Xibrom showed excellent efficacy in the treatment of post cataract surgery pain and inflammation. The trial involved 500 cataract patients and is important in that it demonstrates that a once-a-day formulation is effacacious in treating patients post-operatively. ...
Previous Page : 1 2 3 4 5 6 Next31 to 40 of 56
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Use of Antipsychotics in Children Is Criticized
www.nytimes.com
Scientists recommend 'black box' for Avastin
www.fiercepharma.com
Are Costly Diabetes Pills Doing Any Good?
www.pharmalot.com
How a Drug Maker Tries to Outwit Generics
online.wsj.com
Use of Antipsychotics in Children Poses Risks of Adverse Effects
November 26, 2008
Avastin and clots? News to me. Black box warning? Why?
November 24, 2008
Off Label Use Can Be Prevented
November 24, 2008
Gardasil will most certainly be approved for boys
November 24, 2008
Medivations's (MDVN) Dimebon - We've Seen This Movie Before
November 24, 2008

